Effect of genistein on the activities of cytochrome P450 3A and P-glycoprotein in Chinese healthy participants

References

• Anderle P, Niederer E, Rubas W, Hilgendorf C, Spahn-Langguth H, Wunderli-Allenspach H, Merkle HP, Langguth P. (1998). P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. J Pharm Sci 87:757–762.
   PubMed Web of Science ®Google Scholar
• Appelt LC, Reicks MM. (1997). Soy feeding induces phase II enzymes in rat tissues. Nutr Cancer 28:270–275.
   PubMed Web of Science ®Google Scholar
• Appelt LC, Reicks MM. (1999). Soy induces phase II enzymes but does not inhibit dimethylbenz[a]anthracene-induced carcinogenesis in female rats. J Nutr 129:1820–1826.
   PubMed Web of Science ®Google Scholar
• Ariel F. Castro, Guillermo A., Altenberg. (1997) Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-Glycoprotein. Biochem Pharmacol 53:89–93
   PubMed Web of Science ®Google Scholar
• Axelson M, Sjövall J, Gustafsson BE, Setchell KD. (1984). Soya–a dietary source of the non-steroidal oestrogen equol in man and animals. J Endocrinol 102:49–56.
   PubMed Web of Science ®Google Scholar
• Bernsdorf A, May K, Kuhnert-Keil C, Möritz KU, Kroemer HK, Siegmund W. (2003).Expression of P-glycoprotein and MRP2-deficient rats (GY/TR-) (abstract). Naunyn Schmiedebergs Arch Pharmacol 367:R110.
   Google Scholar
• Boersma BJ, Barnes S, Kirk M, Wang CC, Smith M, Kim H, Xu J, Patel R, Darley-Usmar VM. (2001). Soy isoflavonoids and cancer− metabolism at the target site. Mutat Res 480-481:121–127.
   PubMedGoogle Scholar
• Borrelli F, Izzo AA. (2009). Herb-drug interactions with St John’s wort (Hypericum perforatum): an update on clinical observations. AAPS J 11:710–727.
   PubMed Web of Science ®Google Scholar
• Borst P, Evers R, Kool M, Wijnholds J. (2000). A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 92:1295–1302.
   PubMed Web of Science ®Google Scholar
• Breinholt V, Lauridsen ST, Dragsted LO. (1999). Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat. Xenobiotica 29:1227–1240.
   PubMed Web of Science ®Google Scholar
• Cascorbi I. (2006). Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol Ther 112:457–473.
   PubMed Web of Science ®Google Scholar
• Chen Y, Xiao CQ, He YJ, Chen BL, Wang G, Zhou G, Zhang W, Tan ZR, Cao S, Wang LP, Zhou HH. (2011). Genistein alters caffeine exposure in healthy female volunteers. Eur J Clin Pharmacol 67:347–353.
   PubMedGoogle Scholar
• Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC. (1998). Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280:1569–1575.
   PubMed Web of Science ®Google Scholar
• Foster BC, Vandenhoek S, Hana J, Krantis A, Akhtar MH, Bryan M, Budzinski JW, Ramputh A, Arnason JT. (2003). In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomedicine 10:334–342.
   PubMed Web of Science ®Google Scholar
• Geick A, Eichelbaum M, Burk O. (2001). Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 276:14581–14587.
   PubMed Web of Science ®Google Scholar
• Giessmann T, May K, Modess C, Wegner D, Hecker U, Zschiesche M, Dazert P, Grube M, Schroeder E, Warzok R, Cascorbi I, Kroemer HK, Siegmund W. (2004). Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans. Clin Pharmacol Ther 76:192–200.
   PubMed Web of Science ®Google Scholar
• Harborne, JB. (1994) The flavonoids: Advances in research since 1986. London, Britain: Chapman and Hall.
   Google Scholar
• Limtrakul P, Khantamat O, Pintha K. (2005). Inhibition of P-glycoprotein function and expression by kaempferol and quercetin. J Chemother 17:86–95.
   PubMed Web of Science ®Google Scholar
• Li Y, Ross-Viola JS, Shay NF, Moore DD, Ricketts ML. (2009). Human CYP3A4 and murine Cyp3A11 are regulated by equol and genistein via the pregnane X receptor in a species-specific manner. J Nutr 139:898–904.
   PubMed Web of Science ®Google Scholar
• Lu LJ, Anderson KE, Grady JJ, Nagamani M. (1996). Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev 5:63–70.
   PubMed Web of Science ®Google Scholar
• Ma JD, Tsunoda SM, Bertino JS Jr, Trivedi M, Beale KK, Nafziger AN. (2010). Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation. Clin Pharmacokinet 49:223–237.
   PubMed Web of Science ®Google Scholar
• Martin J Ronis, J. Craig Rowlands, Reza Hakkak, Thomas M Badger. (1999). Altered Expression and Glucocorticoid-Inducibility of Hepatic CYP3A and CYP2B Enzymes in Male Rats Fed Diets Containing Soy Protein Isolate. J Nutr 129:1958–1965
   PubMedGoogle Scholar
• Mirsalis JC, Hamilton CM, Schindler JE, Green CE, Dabbs JE. (1993). Effects of soya bean flakes and liquorice root extract on enzyme induction and toxicity in B6C3F1 mice. Food Chem Toxicol 31:343–350.
   PubMed Web of Science ®Google Scholar
• Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, Collins JL, Kliewer SA. (2000). Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275:15122–15127.
   PubMed Web of Science ®Google Scholar
• Setchell, K. D. R. (1998) Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. American Journal of Clinical Nutrition 68 suppl: 1333S–1346S.
   PubMed Web of Science ®Google Scholar
• Scott LM, Durant P, Leone-Kabler S, Wood CE, Register TC, Townsend A, Cline JM. (2008). Effects of prior oral contraceptive use and soy isoflavonoids on estrogen-metabolizing cytochrome P450 enzymes. J Steroid Biochem Mol Biol 112:179–185.
   PubMed Web of Science ®Google Scholar
• Schwarz UI, Dresser GK, Oertel R, Kim RB. (2001)Talinolol–verapamil interaction is not solely due to P-glycoprotein inhibition (abstract PIII-86).Clin Pharmacol Ther;69:P85.
   Google Scholar
• Schwarz UI, Gramatté T, Krappweis J, Oertel R, Kirch W. (2000). P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans. Int J Clin Pharmacol Ther 38:161–167.
   PubMed Web of Science ®Google Scholar
• Schwarz UI, Hanso H, Oertel R, Miehlke S, Kuhlisch E, Glaeser H, Hitzl M, Dresser GK, Kim RB, Kirch W. (2007). Induction of intestinal P-glycoprotein by St John’s wort reduces the oral bioavailability of talinolol. Clin Pharmacol Ther 81:669–678.
   PubMed Web of Science ®Google Scholar
• Spahn-Langguth H, Langguth P. (2001). Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol. Eur J Pharm Sci 12:361–367.
   PubMed Web of Science ®Google Scholar
• Siegmund W, Ludwig K, Engel G, Zschiesche M, Franke G, Hoffmann A, Terhaag B, Weitschies W. (2003). Variability of intestinal expression of P-glycoprotein in healthy volunteers as described by absorption of talinolol from four bioequivalent tablets. J Pharm Sci 92:604–610.
   PubMed Web of Science ®Google Scholar
• Spahn-Langguth H, Baktir G, Radschuweit A, Okyar A, Terhaag B, Ader P, Hanafy A, Langguth P. (1998). P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound. Int J Clin Pharmacol Ther 36:16–24.
   PubMed Web of Science ®Google Scholar
• Tindle HA, Davis RB, Phillips RS, Eisenberg DM. (2005). Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med 11:42–49.
   PubMed Web of Science ®Google Scholar
• Tirona RG, Lee W, Leake BF, Lan LB, Cline CB, Lamba V, Parviz F, Duncan SA, Inoue Y, Gonzalez FJ, Schuetz EG, Kim RB. (2003). The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 9:220–224.
   PubMed Web of Science ®Google Scholar
• Villeneuve JP, L’Ecuyer L, De Maeght S, Bannon P. (2000). Prediction of cyclosporine clearance in liver transplant recipients by the use of midazolam as a cytochrome P450 3A probe. Clin Pharmacol Ther 67:242–248.
   PubMed Web of Science ®Google Scholar
• Wang G, Xiao CQ, Li Z, Guo D, Chen Y, Fan L, Qian RH, Peng XJ, Hu DL, Zhou HH. (2009). Effect of soy extract administration on losartan pharmacokinetics in healthy female volunteers. Ann Pharmacother 43:1045–1049.
   PubMedGoogle Scholar
• Wei H, Bowen R, Cai Q, Barnes S, Wang Y. (1995). Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208:124–130.
   PubMed Web of Science ®Google Scholar
• Wetterich U, Spahn-Langguth H, Mutschler E, Terhaag B, Rösch W, Langguth P. (1996). Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration- and dose-dependent absorption in vitro and in vivo. Pharm Res 13:514–522.
   PubMed Web of Science ®Google Scholar
• Zhou SF. (2008). Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab 9:310–322.
   PubMed Web of Science ®Google Scholar